Log In
Print this Print this

Dengue fever vaccine (HBV-001 D1)

  Manage Alerts
Collapse Summary General Information
Company Hawaii Biotech Inc.
DescriptionMonovalent recombinant subunit vaccine against dengue fever
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationDengue fever
Indication DetailsVaccinate against dengue fever
Regulatory Designation
PartnerMerck & Co. Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today